SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-063670
Filing Date
2023-11-14
Accepted
2023-11-14 16:00:30
Documents
68
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cfrx-20230930.htm   iXBRL 10-Q 2473366
2 EX-31.1 cfrx-ex31_1.htm EX-31.1 14255
3 EX-31.2 cfrx-ex31_2.htm EX-31.2 14013
4 EX-32.1 cfrx-ex32_1.htm EX-32.1 19569
  Complete submission text file 0000950170-23-063670.txt   8695873

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cfrx-20230930_lab.xml EX-101.LAB 416436
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cfrx-20230930_cal.xml EX-101.CAL 39891
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cfrx-20230930_pre.xml EX-101.PRE 325365
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cfrx-20230930.xsd EX-101.SCH 51898
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cfrx-20230930_def.xml EX-101.DEF 181656
62 EXTRACTED XBRL INSTANCE DOCUMENT cfrx-20230930_htm.xml XML 1519182
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 231405548
SIC: 2834 Pharmaceutical Preparations